Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines
- PMID: 23399758
- PMCID: PMC3899140
- DOI: 10.4161/hv.23871
Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines
Abstract
The pore-forming toxin listeriolysin O (LLO), which is produced by Listeria monocytogenes, mediates bacterial phagosomal escape and facilitates bacterial multiplication during infection. This toxin has recently gained attention because of its confirmed role in the controlled and specific modulation of the immune response. Currently, cancer immunotherapies are focused on conquering the immune tolerance induced by poorly immunogenic tumor antigens and eliciting strong, lasting immunological memory. An effective way to achieve these goals is the co-administration of potent immunomodulatory adjuvant components with vaccine vectors. LLO, a toxin that belongs to the family of cholesterol-dependent cytolysins (CDCs), exhibits potent cell type-non-specific toxicity and is a source of dominant CD4(+) and CD8(+) T cell epitopes. According to recent research, in addition to its effective cytotoxicity as a cancer immunotherapeutic drug, the non-specific adjuvant property of LLO makes it promising for the development of efficacious anti-tumor vaccines.
Keywords: LLO; Listeria; anti-tumor vaccine; cancer immunotherapy; cytotoxicity; immunogenicity; pore-forming toxin.
Figures

Similar articles
-
Multifaceted activity of listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes.Subcell Biochem. 2014;80:161-95. doi: 10.1007/978-94-017-8881-6_9. Subcell Biochem. 2014. PMID: 24798012 Free PMC article. Review.
-
Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.Cancer Res. 2004 Dec 15;64(24):8821-5. doi: 10.1158/0008-5472.CAN-04-1958. Cancer Res. 2004. PMID: 15604239
-
Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.J Immunol. 2005 Sep 15;175(6):3663-73. doi: 10.4049/jimmunol.175.6.3663. J Immunol. 2005. PMID: 16148111
-
Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.Cancer Immunol Immunother. 2008 Apr;57(4):493-505. doi: 10.1007/s00262-007-0388-y. Epub 2007 Sep 18. Cancer Immunol Immunother. 2008. PMID: 17876582 Free PMC article.
-
The relationship between Listeria infections and host immune responses: Listeriolysin O as a potential target.Biomed Pharmacother. 2024 Feb;171:116129. doi: 10.1016/j.biopha.2024.116129. Epub 2024 Jan 8. Biomed Pharmacother. 2024. PMID: 38194738 Review.
Cited by
-
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.Oncoimmunology. 2018 Nov 10;8(2):e1541534. doi: 10.1080/2162402X.2018.1541534. eCollection 2019. Oncoimmunology. 2018. PMID: 30713801 Free PMC article.
-
A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.Vaccine. 2020 Aug 10;38(36):5803-5813. doi: 10.1016/j.vaccine.2020.06.049. Epub 2020 Jul 17. Vaccine. 2020. PMID: 32684498 Free PMC article.
-
Lipid larceny: channelizing host lipids for establishing successful pathogenesis by bacteria.Virulence. 2021 Dec;12(1):195-216. doi: 10.1080/21505594.2020.1869441. Virulence. 2021. PMID: 33356849 Free PMC article. Review.
-
Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells.Int J Mol Sci. 2021 Mar 24;22(7):3305. doi: 10.3390/ijms22073305. Int J Mol Sci. 2021. PMID: 33805017 Free PMC article.
-
Multifaceted activity of listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes.Subcell Biochem. 2014;80:161-95. doi: 10.1007/978-94-017-8881-6_9. Subcell Biochem. 2014. PMID: 24798012 Free PMC article. Review.
References
-
- Paterson Y, Maciag PC. Listeria-based vaccines for cancer treatment. Curr Opin Mol Ther. 2005;7:454–60. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials